Cargando…
Outcomes of Philadelphia Positive Acute Lymphoblastic Leukemia in Adolescent and Young Adults
Background Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) accounts for 25% of acute lymphoblastic leukemia cases in the adolescent and young adult (AYA) age subgroup. It is associated with poor outcomes and is considered a standard indication for allogeneic stem cell transpl...
Autores principales: | Ahmed, Umair, Ahmed, Danyal, Awan, Munazza N, Ahmad, Usman, Ahsan, Bushra, Iftikhar, Raheel, Mir, Muhammad Ayaz, Bokhari, Syed W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835019/ https://www.ncbi.nlm.nih.gov/pubmed/36644079 http://dx.doi.org/10.7759/cureus.32467 |
Ejemplares similares
-
Cytomegalovirus Reactivation in Patients With Acute Lymphoblastic Leukemia in Non-transplant Setting
por: Abbas, Mansoor, et al.
Publicado: (2022) -
Current Concepts in Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
por: Bernt, Kathrin M., et al.
Publicado: (2014) -
Developing an Allogeneic Hematopoietic Progenitor Cell Transplant Service in a Resource-Limited Country: Challenges and Outcomes
por: Mahar, Uzma R, et al.
Publicado: (2023) -
Dasatinib in the Management of Pediatric Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
por: Cerchione, Claudio, et al.
Publicado: (2021) -
Identification of STRBP as a Novel JAK2 Fusion Partner Gene in a Young Adult With Philadelphia Chromosome-Like B-Lymphoblastic Leukemia
por: Zhang, Xin-Yue, et al.
Publicado: (2021)